Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [41] Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
    Tobias Banaschewski
    César Soutullo
    Michel Lecendreux
    Mats Johnson
    Alessandro Zuddas
    Paul Hodgkins
    Ben Adeyi
    Liza A. Squires
    David Coghill
    CNS Drugs, 2013, 27 : 829 - 840
  • [42] Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorderA randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents
    Pär Svanborg
    Gunilla Thernlund
    Per A. Gustafsson
    Bruno Hägglöf
    Lynne Poole
    Björn Kadesjö
    European Child & Adolescent Psychiatry, 2009, 18 : 240 - 249
  • [43] Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial
    Kelsey, DK
    Sumner, CR
    Casat, CD
    Coury, DL
    Quintana, H
    Saylor, KE
    Sutton, VK
    Gonzales, J
    Malcolm, SK
    Schuh, KJ
    Allen, AJ
    PEDIATRICS, 2004, 114 (01) : E1 - E8
  • [44] Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials
    Adler, Lenard A.
    Adams, Julie
    Madera-McDonough, Jessica
    Kohegyi, Eva
    Hobart, Mary
    Chang, Denise
    Angelicola, Mark
    McQuade, Robert
    Liebowitz, Michael
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (05) : 429 - 439
  • [45] Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Johnson, Mats
    Lecendreux, Michel
    Zuddas, Alessandro
    Adeyi, Ben
    Hodgkins, Paul
    Squires, Liza A.
    Coghill, David R.
    CNS DRUGS, 2014, 28 (12) : 1191 - 1203
  • [46] The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research
    Nicola C. Savill
    Jan K. Buitelaar
    Ernie Anand
    Kathleen Ann Day
    Tamás Treuer
    Himanshu P. Upadhyaya
    David Coghill
    CNS Drugs, 2015, 29 : 131 - 151
  • [47] Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis
    Cheng, Jackie Y. W.
    Chen, Ronald Y. L.
    Ko, John S. N.
    Ng, Emil M. L.
    PSYCHOPHARMACOLOGY, 2007, 194 (02) : 197 - 209
  • [48] Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression
    Schwartz, Shimon
    Correll, Christoph U.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (02) : 174 - 187
  • [49] Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis
    Jackie Y. W. Cheng
    Ronald Y. L. Chen
    John S. N. Ko
    Emil M. L. Ng
    Psychopharmacology, 2007, 194 : 197 - 209
  • [50] Effect of Extended-Release Dexmethylphenidate and Mixed Amphetamine Salts on Sleep: A Double-Blind, Randomized, Crossover Study in Youth with Attention-Deficit Hyperactivity Disorder
    J. A. Santisteban
    M. A. Stein
    L. Bergmame
    R. Gruber
    CNS Drugs, 2014, 28 : 825 - 833
12345